Rapid Dose Therapeutics CorpCanadian Securities Exchange:DOSEView on OTC Pink - Current Information
- LAST PRICE0.2700
- TODAY'S CHANGE (%)-0.0100 (-3.5714%)
- Bid / Lots0.2600/ 5
- Ask / Lots0.2700/ 6
- Open / Previous Close0.2750 / 0.2800
- Day Range
- 52 Week Range
- Volume1,500
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DOSE |
|---|---|---|
| 09:32 ET | 500 | 0.275 |
| 10:09 ET | 1000 | 0.27 |
Oct 30, 2024
Rapid Dose Announces Closing of Final Tranche of Common Share Private Placement, from 5:06PM ET on Wednesday Oct 30, 2024 by Dow Jones
5:06PM ET on Wednesday Oct 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Rapid Dose Therapeutics Corp | 34.7M | -5.7x | --- |
Gemina Laboratories Ltd | 42.5M | -11.3x | --- |
NuGen Medical Devices Inc | 21.8M | -2.6x | --- |
Cloud DX Inc | 12.1M | -1.2x | --- |
Justera Health Ltd | 1.2M | -0.5x | --- |
Lattice Biologics Ltd | 4.2M | -3.8x | --- |
Company Information
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. It provides disruptive drug delivery technologies designed to improve patient outcomes. Its flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. It has one operating segment comprising production, distribution, research, and the provision of technical services for the delivery of oral thin film strips containing active ingredients. It offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product.
Contact Information
- Headquarters
- 1121 Walkers Line, Unit 3ABURLINGTON, ON, Canada L7N 2G4
- Phone
- 416-477-1052
- Fax
- 416-509-6509
Executives
- President, Chief Executive Officer, Director
- Mark Upsdell
- Interim Chief Financial Officer
- Doug Hyland
- Senior Vice President - Business Development
- Jason Lewis
- Director
- John Mckimm
- Independent Director
- Marisa Cornacchia
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $34.7M |
|---|---|
Revenue (TTM) | $1.3M |
Shares Outstanding | 128.4M |
Rapid Dose Therapeutics Corp does not pay a dividend. | |
Beta | 1.31 |
EPS | $-0.05 |
Book Value | $-0.03 |
P/E Ratio | -5.7x |
Price/Sales (TTM) | 25.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -401.40% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
